GoldenGolden
Advanced Search
AVM Biotechnology

AVM Biotechnology

AVM Biotechnology is a biotechnology company developing regenerative medicines.

All edits

Edits on 24 Sep, 2021
Aime Anne Nisay"Approved suggestion #1183642"
Aime Anne Nisay approved a suggestion from Golden's AI on 24 Sep, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Wikidata ID
Edits on 7 Jun, 2021
Erin Scherfner"prospector:315:156365"
Erin Scherfner edited on 7 Jun, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Country
United States
Edits on 20 May, 2021
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 20 May, 2021
Edits made to:
Article (+9/-9 characters)
Article

AVM Biotechnology was launched by Dr. Theresa Deisher, Ph.D. With over 30 years of successful pharmaceutical research experience and holding over 47 patents, Dr. Deisher leads a team of scientists who are dedicated to changing what a diagnosis of cancer, autoimmunity, or chronic infectious disease means to patients and their loved ones. The company received FDA IND approval to test its lead product AVM0703 for the treatment of lymphoid malignancies. The mechanism of action that makes AVM0703 work against aggressive cancers may also prove effective against COVID-19. To further that research, AVM Biotechnology has received permission to proceed with clinical trials against this virus as well as InfluenzaInfluenza virus which also causes deadly ARDS.

Nureni Akanji
Nureni Akanji edited on 19 May, 2021
Edits made to:
Article (+1146 characters)
Article

AVM Biotechnology is a biotechnology company that is developing and advancing AVM0703, a patent-pending exclusive formulation. Its AVM0703 triggers the production and release of highly active and powerful novel immune cells.

AVM Biotechnology has the mission to develop and deliver treatments that save lives and improve outcomes by unlocking the untapped potential of the body’s own immune system.

AVM Biotechnology was launched by Dr. Theresa Deisher, Ph.D. With over 30 years of successful pharmaceutical research experience and holding over 47 patents, Dr. Deisher leads a team of scientists who are dedicated to changing what a diagnosis of cancer, autoimmunity, or chronic infectious disease means to patients and their loved ones. The company received FDA IND approval to test its lead product AVM0703 for the treatment of lymphoid malignancies. The mechanism of action that makes AVM0703 work against aggressive cancers may also prove effective against COVID-19. To further that research, AVM Biotechnology has received permission to proceed with clinical trials against this virus as well as Influenza virus which also causes deadly ARDS.

Edits on 22 Feb, 2021
Golden AI"Setting founded date to the company's date of incorporation."
Golden AI edited on 22 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Founded date
2008
Edits on 19 Mar, 2019
Dawson Sewell
Dawson Sewell edited on 19 Mar, 2019
Edits made to:
Infobox (+10 properties)
Description (+79/-31 characters)
People (-1 rows) (-2 cells) (-21 characters)
Further reading (+3 rows) (+11 cells) (+607 characters)
Documentaries, videos and podcasts (+2 rows) (+6 cells) (+243 characters)
Categories (+2/-2 topics)
Related Topics (+2 topics)
Topic thumbnail

AVM Biotechnology

A regenerative medicine company

AVM Biotechnology is a biotechnology company developing regenerative medicines.

People

Name
Role
Related Golden topics

Michael Kuran

Employee

Further reading

Title
Author
Link
Type

AVM Biotechnology raising $17.5M to improve safety and delivery of stem cells

Web

Biotech Firm To Provide Ethical Alternatives For All Aborted Fetal Vaccines

Children of God for life

Web

This biotech company may be on the verge of a boom - but they only want pro-life investors

Steve Weatherbe

Web

Documentaries, videos and podcasts

Title
Date
Link

AVM Biotechnology - How Stem Cells Work and the Science of the Spleen

June 6, 2017

AVM Biotechnology Presents at Biotech & Money in London, UK

February 13, 2018

Infobox
Location
Date incorporated
2008
Categories
Related Topics
Edits on 21 Jan, 2019
Golden AI"Changed markets to industries"
Golden AI edited on 21 Jan, 2019
Edits made to:
Infobox (+1/-1 properties)
Infobox
Edits on 10 Jan, 2019
Golden AI
Golden AI edited on 10 Jan, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 12 Dec, 2018
Golden AI"Import data"
Golden AI edited on 12 Dec, 2018
Edits made to:
Infobox (+4 properties)
People (+1 rows) (+2 cells) (+21 characters)
Categories (+1 topics)
People

Name
Role
Related Golden topics

Michael Kuran

Employee

Infobox
Categories
Edits on 1 Sep, 2018
Golden AI"Update description"
Golden AI edited on 1 Sep, 2018
Edits made to:
Description (+31/-21 characters)
Topic thumbnail

AVM Biotechnology

Biotechnology company

A regenerative medicine company

Edits on 19 Jul, 2018
Golden AI"Update locations in infobox"
Golden AI edited on 19 Jul, 2018
Infobox
Location
Edits on 29 Jun, 2018
Golden AI"Update infobox"
Golden AI edited on 29 Jun, 2018
Infobox
Edits on 29 May, 2018
Golden AI"Initial topic creation"
Golden AI created this topic on 29 May, 2018
Edits made to:
Description (+21 characters)
Categories (+1 topics)
Topic thumbnail

 AVM Biotechnology

Biotechnology company

Categories
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.